Aytu BioPharma

About:

Aytu BioPharma is a specialty healthcare company focused on developing treatments for urological and related conditions.

Website: http://aytubio.com/

Top Investors: Avenue Capital Group, Nantahala Capital Management, Eclipse Business Capital, Stonepine Capital Management

Description:

Aytu BioScience is a specialty healthcare company concentrating on developing products for redox-modulated conditions with a focus on urological indications and related conditions. Aytu BioScience is initially concentrating on male sexual dysfunction and male infertility and will seek expansion opportunities in other urological indications.

Total Funding Amount:

$52.5M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Englewood, Colorado, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)aytubio.com

Founders:

Josh Disbrow

Number of Employees:

101-250

Last Funding Date:

2024-06-14

IPO Status:

Public

Industries:

© 2025 bioDAO.ai